[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357316-105":59,"doc-detail-357316-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","appendiceal-mucinous-neoplasms-and-pseudomyxoma-peritonei-current-classification-and-the-role-of-intraperitoneal-chemotherapy","Appendiceal Mucinous Neoplasms and Pseudomyxoma Peritonei - Current Classification and the Role of Intraperitoneal Chemotherapy","","Appendiceal mucinous neoplasms (AMNs) and pseudomyxoma peritonei (PMP) are rare peritoneal surface malignancies driven by mucin production and progressive intraperitoneal dissemination. Clinical management has shifted toward cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC), yet recurrence and treatment resistance remain frequent, especially in high-grade disease. The review synthesizes histopathological and molecular classification and evaluates current intraperitoneal strategies including HIPEC and PIPAC, highlighting KRAS and GNAS mutations, grade and mucin cellularity as key prognostic factors. It emphasizes organoid-based translational modeling to support more biologically informed, individualized therapy selection.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/appendiceal-mucinous-neoplasms-and-pseudomyxoma-peritonei-current-classification-and-the-role-of-intraperitoneal-chemotherapy/357316/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/appendiceal-mucinous-neoplasms-and-pseudomyxoma-peritonei-current-classification-and-the-role-of-intraperitoneal-chemotherapy/357316.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are appendiceal mucinous neoplasms and pseudomyxoma peritonei characterized by?","Question",{"text":113,"@type":114},"They are rare malignancies characterized by mucin production and progressive dissemination within the peritoneal cavity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is CRS/HIPEC considered standard care for selected patients?",{"text":118,"@type":114},"Combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has substantially improved outcomes for conditions such as pseudomyxoma peritonei and peritoneal mesothelioma.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular and clinical factors are highlighted as important in disease behavior and prognosis?",{"text":122,"@type":114},"KRAS and GNAS mutations are central drivers of mucin overproduction and peritoneal spread, while tumor grade and mucin cellularity are described as the strongest prognostic determinants.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},357316,1790557958,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":24,"preview_urls":147},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nAppendiceal Mucinous Neoplasms and Pseudomyxoma Peritonei: Current Classification and the Role of Intraperitoneal Chemotherapy  \nWalter Giuseppe Giordano 1, *, Giovanbattista Musumeci 2, Enrica Nasso 3, Alessandra Briguglio 2, Ferdinando Macrì 1, Angela D’Ascola 3, Antonio Ieni 1 and Antonio Macrì 2  \nAcademic Editor: Guido Alberto Massimo Tiberio  \nReceived: 21 May 2026  \nRevised: 9 June 2026  \nAccepted: 11 June 2026  \nPublished: 19 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Human Pathology of the Adulthood and Developing Age “Gaetano Barresi”, Section of Pathology, University of Messina, 98122 Messina, Italy; [ferdinando.macri.2110@gmail.com](ferdinando.macri.2110@gmail.com) (F.M.); [antonio.ieni@unime.it](antonio.ieni@unime.it) (A.I.)  \n2 General and Emergency Surgery Unit, Azienda Ospedaliera Universitaria “G. Martino”—Messina,  \n98125 Messina, Italy; [gbmusumeci@gmail.com](gbmusumeci@gmail.com) (G.M.); [briguglioalessandra@gmail.com](briguglioalessandra@gmail.com) (A.B.);  \n[antonio.macri@unime.it](antonio.macri@unime.it) (A.M.)  \n3 Department of Clinical and Experimental Medicine, Policlinic “G. Martino”, University of Messina,  \n98122 Messina, Italy; [enrica@nasso.it](enrica@nasso.it) (E.N.); [angela.dascola@unime.it](angela.dascola@unime.it) (A.D.)  \n* [Correspondence: walter.giordano@studenti.unime.it](Correspondence: walter.giordano@studenti.unime.it)  \nSimple Summary  \nAppendiceal mucinous neoplasms (AMNs) and pseudomyxoma peritonei (PMP) are rare malignancies characterized by mucin production and progressive dissemination within the peritoneal cavity. Over the past decades, the combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has significantly improved patient survival and represents the current standard of care for selected patients. However, recurrence remains common, particularly in high-grade disease, and the biological mechanisms underlying tumor progression and therapeutic resistance are still incompletely understood. Despite numerous reviews addressing the surgical management of these tumors, an integrated perspective that links their evolving histopathological and molecular classification to current and emerging intraperitoneal treatment strategies is still lacking. This review addresses that gap by bringing together, in a single framework, the current classification of AMNs and PMP, the role and evolution of intraperitoneal chemotherapy strategies including HIPEC and PIPAC, and the molecular alterations that drive disease behavior. Its main novelty lies in connecting these molecular insights with emerging translational approaches, particularly patient-derived organoids, which may improve preclinical modelling, drug testing, and personalized treatment selection. Together, these advances support the transition toward more biologically informed and individualized therapeutic strategies for peritoneal surface malignancies.  \nAbstract  \nAppendiceal mucinous neoplasms (AMNs) are a rare but clinically significant category of gastrointestinal tumors, ranging from low-grade appendiceal mucinous neoplasm (LAMN), the main precursor of pseudomyxoma peritonei (PMP), to high-grade appendiceal mucinous neoplasm (HAMN), poorly differentiated and signet-ring-cell adenocarcinomas, and goblet cell adenocarcinoma. Although current WHO and PSOGI classifications provide well established diagnostic criteria, controversies persist regarding the biological behavior and prognostic significance of the most aggressive subtypes and the relationship between HAMN and mucinous adenocarcinoma. While appendectomy is sufficient for localized LAMN, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy  \n(CRS/HIPEC) is the treatment of choice for peritoneal dissemination This review i","cbCaifEJ4CbozzKJ","https://ap.wps.com/l/cbCaifEJ4CbozzKJ","pdf",2727788,41,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What are appendiceal mucinous neoplasms and pseudomyxoma peritonei characterized by?\",\"answer\":\"They are rare malignancies characterized by mucin production and progressive dissemination within the peritoneal cavity.\"},{\"question\":\"Why is CRS/HIPEC considered standard care for selected patients?\",\"answer\":\"Combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has substantially improved outcomes for conditions such as pseudomyxoma peritonei and peritoneal mesothelioma.\"},{\"question\":\"Which molecular and clinical factors are highlighted as important in disease behavior and prognosis?\",\"answer\":\"KRAS and GNAS mutations are central drivers of mucin overproduction and peritoneal spread, while tumor grade and mucin cellularity are described as the strongest prognostic determinants.\"}]","Appendiceal Mucinous Neoplasms and Pseudomyxoma Peritonei - Current Classification and the Role of Intraperitoneal Chemotherapy | PDF",1790129602,103,[148,152,156,160,164],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4d0d96114c64f2a6d3fda2e37a22e0d.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed53f365c72bf64cef82910224e10b58.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6eda03c50502e19ba179dc7a14e08ec6.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/562812cf439863db67b5a5d002ee05fd.webp",980,1385,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77648f24e52685eb55b5f6b4922db139.webp",979,1384]